Waters Corporation ROE

ROE of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.


Highlights and Quick Summary

  • Annual ROE for 2020 was 6576.65% (a 7401.6% increase from previous year)
  • Annual ROE for 2019 was 87.67% (a 180.63% increase from previous year)
  • Annual ROE for 2018 was 31.24% (a 3371.11% increase from previous year)
  • Twelve month ROE ending December 30, 2020 was 6576.65% (a 382.35% increase compared to previous quarter)
  • Twelve month trailing ROE increased by 3757.95% year-over-year
Trailing ROE for the last four month:
30 Dec '20 29 Sep '20 29 Jun '20 30 Mar '20
6576.65% 1363.45% 282.74% 170.47%
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of Waters Corporation

Most recent ROEof WAT including historical data for past 10 years.

Interactive Chart of ROE of Waters Corporation

Waters Corporation ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 6576.65%
2019 87.67%
2018 31.24%
2017 0.9%
2016 23.92%
2015 23.73%
2014 23.6%
2013 27.86%
2012 34.26%
2011 37.73%
2010 39.81%

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.